Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Melanoma

  Free Subscription


23.09.2024

5 Am J Dermatopathol
1 Ann Surg Oncol
3 J Am Acad Dermatol
1 J Clin Invest
1 J Invest Dermatol
1 Melanoma Res
2 N Engl J Med
1 Oncol Rep


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Dermatopathol

  1. DARUISH M, Kerr G, Taibjee S
    A Combined Spindle Cell Melanoma and Sarcomatoid Squamous Cell Carcinoma: A Rather Unique Squamomelanocytic Tumor.
    Am J Dermatopathol. 2024 Sep 17. doi: 10.1097/DAD.0000000000002838.
    PubMed         Abstract available

  2. SINGH P, Wu D, Karunamurthy A, Seynnaeve BKN, et al
    Pediatric Melanoma With a Rare BRAF V600K Mutation.
    Am J Dermatopathol. 2024 Sep 17. doi: 10.1097/DAD.0000000000002835.
    PubMed        

  3. NG S, Hall KC, Busam KJ, Lezcano C, et al
    Superficial Wnt-Activated Melanocytic Nevi/Melanocytomas With a Junctional Component: A Case Series.
    Am J Dermatopathol. 2024 Aug 14. doi: 10.1097/DAD.0000000000002804.
    PubMed         Abstract available

  4. MERT M, Bozdogan O, Bozdogan N, Gamsizkan M, et al
    PRAME and Historical Immunohistochemical Antibodies Ki-67, P16, and HMB-45 in Ambiguous Melanocytic Tumors.
    Am J Dermatopathol. 2024 Jun 20. doi: 10.1097/DAD.0000000000002768.
    PubMed         Abstract available

  5. KNITTEL R, Rogers S, Wood BA
    Cutaneous Seeding of Glioblastoma: A Case Report and Literature Review.
    Am J Dermatopathol. 2024 Jun 6. doi: 10.1097/DAD.0000000000002748.
    PubMed         Abstract available


    Ann Surg Oncol

  6. ROJAS-GARCIA P, Ma B, Jonsson EL, Genereux O, et al
    ASO Visual Abstract: Using Nomograms Wisely-Predicting Sentinel Node Positivity in Melanoma.
    Ann Surg Oncol. 2024 Sep 21. doi: 10.1245/s10434-024-16074.
    PubMed        


    J Am Acad Dermatol

  7. TAYLOR MA, Sharma D, Thomas SI, Ituarte BE, et al
    Examining Racial and Ethnic Disparities in Cutaneous Melanoma of the Head and Neck.
    J Am Acad Dermatol. 2024 Sep 15:S0190-9622(24)02829.
    PubMed        

  8. TAYLOR MA, Sharma D, Thomas S, Wei EX, et al
    Improved disease-specific survival in head and neck cutaneous melanomas treated with Mohs surgery over wide local excision in the United States.
    J Am Acad Dermatol. 2024 Sep 13:S0190-9622(24)02724.
    PubMed        

  9. MONCAYO AK, Grossman D, Kim CC, Hartman RI, et al
    Response to Bass et al's "Significant discordance in DermTech test results when paired with histopathology: Caveat emptor".
    J Am Acad Dermatol. 2024;91:e101-e102.
    PubMed        


    J Clin Invest

  10. LI ZJ, He B, Domenichini A, Satiaputra J, et al
    Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical models.
    J Clin Invest. 2024;134:e179860.
    PubMed         Abstract available


    J Invest Dermatol

  11. CHHABRA G, Ahmad N
    Mystery of Melanotransferrin in Melanoma.
    J Invest Dermatol. 2024 Sep 14:S0022-202X(24)01994.
    PubMed        


    Melanoma Res

  12. STAWIARZ M, Hoang MP, Kowalik A
    High-resolution RNA-sequencing reveals TRIM33::CSDE1 gene fusion in metastasizing vulvar melanoma.
    Melanoma Res. 2024 Sep 18. doi: 10.1097/CMR.0000000000001005.
    PubMed         Abstract available


    N Engl J Med

  13. RUBIN EJ, Yeku OO, Morrissey S
    NEJM at ESMO - Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2024 Sep 15. doi: 10.1056/NEJMe2411489.
    PubMed        

  14. WOLCHOK JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, et al
    Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2024 Sep 15. doi: 10.1056/NEJMoa2407417.
    PubMed         Abstract available


    Oncol Rep

  15. ZHONG Q, Li D, Yang XP
    Progress in antitumor mechanisms and applications of phenformin (Review).
    Oncol Rep. 2024;52:151.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.